Industry Sponsored Clinical Trials Indirect Cost Rates
The industry sponsored clinical trials indirect rate is set by the Office of Research and Innovation in coordination with the College of Medicine and Research Accounting Services. This rate is to be applied for all industry sponsored clinical trials/research. Federally sponsored clinical trials must use the federally negotiated indirect cost rate. The current and historical rates are listed below:
Effective April 1, 2021 |
Prior to April 1, 2021 |
|
Industry Sponsored Clinical Trials Indirect Cost Rate |
35% | 30% |
For questions concerning the use of the industry sponsored clinical trials indirect cost rate, please contact ras@drexel.edu.